<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0010536'>Central sleep apnea</z:hpo> (CSA) results from a reduction in lack of output from the central respiratory generator in the brainstem, manifesting as <z:hpo ids='HP_0002104'>apneas</z:hpo> and <z:mp ids='MP_0001956'>hypopneas</z:mp> without discernible efforts </plain></SENT>
<SENT sid="1" pm="."><plain>CSA can lead to hypercarbia, <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo>, and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Indeed, the patient may develop a disturbed breathing during sedation procedures </plain></SENT>
<SENT sid="3" pm="."><plain>We report a patient who was diagnosed with CSA and had been on continuous positive airway pressure (CPAP) therapy for 5 years </plain></SENT>
<SENT sid="4" pm="."><plain>He was referred for multiple tooth extractions under sedation owing to severe gag reflex and phobic <z:hpo ids='HP_0000739'>anxiety</z:hpo> disorder </plain></SENT>
<SENT sid="5" pm="."><plain>The treatment was completed uneventfully under N(2)O and <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> inhalation accompanied by midazolam and ketamine induction </plain></SENT>
<SENT sid="6" pm="."><plain>The role of sedative, <z:chebi fb="29" ids="35480">analgesic</z:chebi>, and <z:chebi fb="0" ids="38867">anesthetic agents</z:chebi> as a precipitating factor for CSA is of particular concern </plain></SENT>
<SENT sid="7" pm="."><plain>The combined administration of midazolam, ketamine, <z:chebi fb="0" ids="9130">sevoflurane</z:chebi>, and N(2)O/<z:chebi fb="0" ids="15379">O(2)</z:chebi> is a useful and safe option for patients requiring sedation </plain></SENT>
</text></document>